catalyst · primary record
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
FDA filing · 2026-08-11
| Company | AUROBINDO PHARMA LIMITED |
|---|---|
| Ticker | Not stated |
| Impact | medium |
| Detail | Original Application · Tentative Approval |
| Source | openFDA |
Provenance
- Source: openFDA
- Fetched at: 2026-10-28T10:41:01.804Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: AUROBINDO PHARMA LIMITED:CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE:2026-08-11:Original Application · Tentative Approval
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.